Free Trial

Zynex (ZYXI) News Today

Zynex logo
$7.86 +0.04 (+0.51%)
(As of 11/20/2024 ET)
Zynex, Inc. stock logo
Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead Sells 10,000 Shares
Zynex, Inc. (NASDAQ:ZYXI - Get Free Report) CFO Daniel J. Moorhead sold 10,000 shares of the business's stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $8.59, for a total transaction of $85,900.00. Following the sale, the chief financial officer now owns 44,878 shares of the company's stock, valued at $385,502.02. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
RBC Capital Keeps Their Buy Rating on Zynex (ZYXI)
Zynex sees 2024 EPS at least 20c, consensus 20c
Zynex, Inc. stock logo
Zynex (NASDAQ:ZYXI) Announces Quarterly Earnings Results
Zynex (NASDAQ:ZYXI - Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.01. The company had revenue of $49.97 million for the quarter, compared to analyst estimates of $50.83 million. Zynex had a return on equity of 14.15% and a net margin of 3.12%. The company's revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter last year, the company posted $0.10 EPS.
Zynex price target raised to $17 from $16 at H.C. Wainwright
Zynex, Inc. stock logo
Zynex (NASDAQ:ZYXI) Price Target Raised to $17.00 at HC Wainwright
HC Wainwright increased their price target on shares of Zynex from $16.00 to $17.00 and gave the stock a "buy" rating in a research report on Friday.
Zynex, Inc. (ZYXI) Q3 2024 Earnings Call Transcript
Zynex, Inc. stock logo
Zynex (NASDAQ:ZYXI) Updates FY 2024 Earnings Guidance
Zynex (NASDAQ:ZYXI) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.200- for the period, compared to the consensus estimate of 0.200. The company also issued revenue guidance of $200.0 millionillion-, compared to the consensus estimate of $200.5 millionillion.
Zynex Reports Third Quarter 2024 Financial Results
Zynex Sets Third Quarter 2024 Earnings Call
Zynex, Inc. stock logo
AQR Capital Management LLC Sells 67,148 Shares of Zynex, Inc. (NASDAQ:ZYXI)
AQR Capital Management LLC lowered its position in shares of Zynex, Inc. (NASDAQ:ZYXI - Free Report) by 63.0% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,439 shares of the company's stock after se
Zynex, Inc. stock logo
Millennium Management LLC Acquires 118,615 Shares of Zynex, Inc. (NASDAQ:ZYXI)
Millennium Management LLC increased its holdings in shares of Zynex, Inc. (NASDAQ:ZYXI - Free Report) by 66.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 297,082 shares of the company's stock af
Zynex, Inc.: 2025 Looks Like A Brighter Year
Zynex, Inc. stock logo
Zynex (NASDAQ:ZYXI) Given New $11.00 Price Target at Royal Bank of Canada
Royal Bank of Canada reduced their price target on Zynex from $12.00 to $11.00 and set an "outperform" rating for the company in a research report on Tuesday.
Zynex, Inc. stock logo
Renaissance Technologies LLC Raises Position in Zynex, Inc. (NASDAQ:ZYXI)
Renaissance Technologies LLC increased its holdings in shares of Zynex, Inc. (NASDAQ:ZYXI - Free Report) by 68.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 189,762 shares of the company's stock af
Buy Rating Affirmed for Zynex on FDA Clearance and Solid Growth Prospects
Zynex, Inc. stock logo
Zynex's (ZYXI) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright restated a "buy" rating and set a $16.00 price target on shares of Zynex in a research report on Wednesday.
Zynex Receives FDA Clearance For New TensWave Device
Zynex pain management device TensWave achieves FDA clearance
Zynex, Inc. stock logo
Janus Henderson Group PLC Sells 76,126 Shares of Zynex, Inc. (NASDAQ:ZYXI)
Janus Henderson Group PLC cut its stake in shares of Zynex, Inc. (NASDAQ:ZYXI - Free Report) by 72.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,781 shares of the company's stock after se
Zynex, Inc. stock logo
HC Wainwright Analysts Reduce Earnings Estimates for Zynex, Inc. (NASDAQ:ZYXI)
Zynex, Inc. (NASDAQ:ZYXI - Free Report) - HC Wainwright cut their Q1 2025 earnings per share (EPS) estimates for Zynex in a report issued on Friday, July 26th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of $0.10 per share for the quarter, down from their previou
Zynex, Inc. stock logo
Zynex (NASDAQ:ZYXI) Issues Earnings Results, Misses Expectations By $0.04 EPS
Zynex (NASDAQ:ZYXI - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). Zynex had a return on equity of 16.34% and a net margin of 4.33%. The firm had revenue of $49.88 million during the quarter, compared to the consensus estimate of $51.99 million. During the same period in the previous year, the firm earned $0.09 EPS. The business's revenue was up 11.0% on a year-over-year basis.
Why Zynex Plunged Today
Get Zynex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

ZYXI Media Mentions By Week

ZYXI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZYXI
News Sentiment

-0.34

0.46

Average
Medical
News Sentiment

ZYXI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZYXI Articles
This Week

1

2

ZYXI Articles
Average Week

Get Zynex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZYXI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners